Literature DB >> 23150881

The tetraspanin CD37 orchestrates the α(4)β(1) integrin-Akt signaling axis and supports long-lived plasma cell survival.

Annemiek B van Spriel1, Sandra de Keijzer, Alie van der Schaaf, Kate H Gartlan, Mariam Sofi, Amanda Light, Peter C Linssen, Jan B Boezeman, Malou Zuidscherwoude, Inge Reinieren-Beeren, Alessandra Cambi, Fabienne Mackay, David M Tarlinton, Carl G Figdor, Mark D Wright.   

Abstract

Signaling by the serine and threonine kinase Akt (also known as protein kinase B), a pathway that is common to all eukaryotic cells, is central to cell survival, proliferation, and gene induction. We sought to elucidate the mechanisms underlying regulation of the kinase activity of Akt in the immune system. We found that the four-transmembrane protein CD37 was essential for B cell survival and long-lived protective immunity. CD37-deficient (Cd37(-/-)) mice had reduced numbers of immunoglobulin G (IgG)-secreting plasma cells in lymphoid organs compared to those in wild-type mice, which we attributed to increased apoptosis of plasma cells in the germinal centers of the spleen, areas in which B cells proliferate and are selected. CD37 was required for the survival of IgG-secreting plasma cells in response to binding of vascular cell adhesion molecule 1 to the α(4)β(1) integrin. Impaired α(4)β(1) integrin-dependent Akt signaling in Cd37(-/-) IgG-secreting plasma cells was the underlying cause responsible for impaired cell survival. CD37 was required for the mobility and clustering of α(4)β(1) integrins in the plasma membrane, thus regulating the membrane distribution of α(4)β(1) integrin necessary for activation of the Akt survival pathway in the immune system.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23150881     DOI: 10.1126/scisignal.2003113

Source DB:  PubMed          Journal:  Sci Signal        ISSN: 1945-0877            Impact factor:   8.192


  44 in total

1.  Mitochondrial Pyruvate Import Promotes Long-Term Survival of Antibody-Secreting Plasma Cells.

Authors:  Wing Y Lam; Amy M Becker; Krista M Kennerly; Rachel Wong; Jonathan D Curtis; Elizabeth M Llufrio; Kyle S McCommis; Johannes Fahrmann; Hannah A Pizzato; Ryan M Nunley; Jieun Lee; Michael J Wolfgang; Gary J Patti; Brian N Finck; Erika L Pearce; Deepta Bhattacharya
Journal:  Immunity       Date:  2016-07-05       Impact factor: 31.745

2.  Extrafollicular CD4 T cell-derived IL-10 functions rapidly and transiently to support anti-Plasmodium humoral immunity.

Authors:  Fionna A Surette; Jenna J Guthmiller; Lei Li; Alexandria J Sturtz; Rahul Vijay; Rosemary L Pope; Brandon L McClellan; Angela D Pack; Ryan A Zander; Peng Shao; Linda Yu-Ling Lan; Daniel Fernandez-Ruiz; William R Heath; Patrick C Wilson; Noah S Butler
Journal:  PLoS Pathog       Date:  2021-02-02       Impact factor: 6.823

3.  Six-packed antibodies punch better.

Authors:  Christoph Rader; Adrian Wiestner
Journal:  Haematologica       Date:  2019-09       Impact factor: 9.941

4.  Crystal Structure of a Full-Length Human Tetraspanin Reveals a Cholesterol-Binding Pocket.

Authors:  Brandon Zimmerman; Brendan Kelly; Brian J McMillan; Tom C M Seegar; Ron O Dror; Andrew C Kruse; Stephen C Blacklow
Journal:  Cell       Date:  2016-10-27       Impact factor: 41.582

5.  Assessment of CD37 B-cell antigen and cell of origin significantly improves risk prediction in diffuse large B-cell lymphoma.

Authors:  Zijun Y Xu-Monette; Ling Li; John C Byrd; Kausar J Jabbar; Ganiraju C Manyam; Charlotte Maria de Winde; Michiel van den Brand; Alexandar Tzankov; Carlo Visco; Jing Wang; Karen Dybkaer; April Chiu; Attilio Orazi; Youli Zu; Govind Bhagat; Kristy L Richards; Eric D Hsi; William W L Choi; Jooryung Huh; Maurilio Ponzoni; Andrés J M Ferreri; Michael B Møller; Ben M Parsons; Jane N Winter; Michael Wang; Frederick B Hagemeister; Miguel A Piris; J Han van Krieken; L Jeffrey Medeiros; Yong Li; Annemiek B van Spriel; Ken H Young
Journal:  Blood       Date:  2016-10-19       Impact factor: 22.113

Review 6.  Immunological memory in rheumatic inflammation - a roadblock to tolerance induction.

Authors:  Patrick Maschmeyer; Hyun-Dong Chang; Qingyu Cheng; Mir-Farzin Mashreghi; Falk Hiepe; Tobias Alexander; Andreas Radbruch
Journal:  Nat Rev Rheumatol       Date:  2021-04-06       Impact factor: 20.543

Review 7.  Antibody-Drug Conjugates for the Treatment of Hematological Malignancies: A Comprehensive Review.

Authors:  Cédric Rossi; Marie-Lorraine Chrétien; René-Olivier Casasnovas
Journal:  Target Oncol       Date:  2018-06       Impact factor: 4.493

8.  TSPAN33 is a novel marker of activated and malignant B cells.

Authors:  Van Phi Luu; Peter Hevezi; Felipe Vences-Catalan; José Luis Maravillas-Montero; Clayton Alexander White; Paolo Casali; Luis Llorente; Juan Jakez-Ocampo; Guadalupe Lima; Natalia Vilches-Cisneros; Juan Pablo Flores-Gutiérrez; Leopoldo Santos-Argumedo; Albert Zlotnik
Journal:  Clin Immunol       Date:  2013-08-15       Impact factor: 3.969

9.  Tetraspanin CD37 protects against the development of B cell lymphoma.

Authors:  Charlotte M de Winde; Sharon Veenbergen; Ken H Young; Zijun Y Xu-Monette; Xiao-Xiao Wang; Yi Xia; Kausar J Jabbar; Michiel van den Brand; Alie van der Schaaf; Suraya Elfrink; Inge S van Houdt; Marion J Gijbels; Fons A J van de Loo; Miranda B Bennink; Konnie M Hebeda; Patricia J T A Groenen; J Han van Krieken; Carl G Figdor; Annemiek B van Spriel
Journal:  J Clin Invest       Date:  2016-01-19       Impact factor: 14.808

10.  Constrained chromatin accessibility in PU.1-mutated agammaglobulinemia patients.

Authors:  Carole Le Coz; David N Nguyen; Chun Su; Brian E Nolan; Amanda V Albrecht; Suela Xhani; Di Sun; Benjamin Demaree; Piyush Pillarisetti; Caroline Khanna; Francis Wright; Peixin Amy Chen; Samuel Yoon; Amy L Stiegler; Kelly Maurer; James P Garifallou; Amy Rymaszewski; Steven H Kroft; Timothy S Olson; Alix E Seif; Gerald Wertheim; Struan F A Grant; Linda T Vo; Jennifer M Puck; Kathleen E Sullivan; John M Routes; Viktoria Zakharova; Anna Shcherbina; Anna Mukhina; Natasha L Rudy; Anna C E Hurst; T Prescott Atkinson; Titus J Boggon; Hakon Hakonarson; Adam R Abate; Joud Hajjar; Sarah K Nicholas; James R Lupski; James Verbsky; Ivan K Chinn; Michael V Gonzalez; Andrew D Wells; Alex Marson; Gregory M K Poon; Neil Romberg
Journal:  J Exp Med       Date:  2021-05-05       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.